BTS/SIGN/NICE Joint Guideline for the Diagnosis, Monitoring and Management of Chronic Asthma

BTS/SIGN/NICE Joint Guideline for the Diagnosis, Monitoring and Management of Chronic Asthma

The British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN), have produced a joint Guideline for the Diagnosis, Monitoring and Management of Chronic Asthma. The guideline can be accessed via this link: Joint Guideline on Diagnosis, Monitoring and Management of Chronic Asthma NG245

A session on the new Guideline was presented at the BTS Winter Meeting on 28 November 2024. 
You can watch a recording of the session here

The Guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks, however these are covered in the Asthma pathway linked below. The Guideline updates and replaces NICE Guideline 80 (published November 2017) and parts of BTS/SIGN British Guideline SIGN 158 (published July 2019).

A Joint Asthma Pathway

BTS, NICE and SIGN have developed a joint asthma pathway, which brings together recommendations on diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It also covers managing difficult and severe asthma and acute asthma attacks. The pathway can be linked via Health Improvement Scotland's Right Decision Service here, or via the NICE website here.

Any queries about the BTS/SIGN/NICE Joint Guideline for the Diagnosis, Monitoring and Management of Chronic Asthma should be sent to  asthmaenquiries@nice.org.uk

Current

Previous